Determination of celiac disease frequency in type 1 diabetes mellitus children in the Pediatric Endocrinology Clinic of Sari, Mazandaran by Zamanfar, Daniel et al.
  
 
 
 
 
 
Daniel Zamanfar (MD)
 
*
1
 
Mohsen Aarabi (MD)
 2 
Hasan Karami (MD)
 3
 
Yousef Karimzad (MD)
 4
 
Mahila Monajati (Pharm D)
 5
 
 
1. Assistant Professor of Pediatric 
Endocrinology, Diabetes Research Center 
of Mazandaran, Mazandaran University of 
Medical Sciences, Sari, Iran. 
2. Assistant Professor of Epidemiology, 
Ischemic Disorders Research Center, 
Golestan University of Medical Sciences, 
Gorgan, Iran.  
3. Associate Professor of Pediatric 
Gastroenterology, Faculty of Medicine, 
Mazandaran University of Medical 
Sciences, Sari, Iran. 
4. Mazandaran University of Medical 
Sciences, Sari, Iran. 
5. Resident of Clinical Pharmacy, 
Mazandaran University of Medical 
Sciences, Sari, Iran. 
 
 Correspondence:  
Daniel Zamanfar (MD), Pediatric 
Endocrinology Division, Boo-Ali Sina 
Hospital, Sari, IR Iran. 
 
E-mail: danielzamanfar@yahoo.com 
Tel: +98 1133342338 
Fax: +98 1133342338 
 
 
 
Original Article 
 
Received: 8 Dec 2017 
Revised: 5 Jan 2018 
Accepted: 1 Feb 2018 
Citation: 
Zamanfar D, Aarabi M, Karami H, et al. Determination of celiac disease 
frequency in type 1 diabetic children in the Pediatric Endocrinology Clinic 
of Sari, Mazandaran. Caspian J Pediatr March 2018; 4(1): 265-70. 
Determination of celiac disease frequency in type 1 diabetes mellitus 
children in the Pediatric Endocrinology Clinic of Sari, Mazandaran 
 
Abstract: 
Background: Diabetes mellitus, type 1 (T1DM) and celiac disease (CD) 
are both immune-mediated. The mean rate of clinical overlap is 8%. The 
aim of this study was to discover the frequency of CD in children with 
type 1 diabetes in Mazandaran province. 
Methods: This retrospective descriptive study was performed in the 
pediatric endocrinology referral center, in Sari from 2012 to 2014. We 
screened all individuals aged between six months and 18 years with 
diabetes diagnosis after ketoacidosis, positive anti-GAD 65 antibodies, 
and insulin therapy. Patients with a positive tissue Transglutaminase 
Immunoglobulin A (tTG-IgA) antibodies test underwent endoscopic 
biopsy. Categorical data were tested using chi-square and quantitative 
data with independent sample T-test in SPSS. Date reported with 95% 
confidence interval. P<0.05 was considered statically significant. 
Results: Of the 119 children enrolled, six cases (5%) were positive for 
tTG-IgA antibodies and all of them were boys (P=0.013). 
Histopathologically, CD was confirmed in 5 persons (4.2%). The mean 
age of seropositive patients was 10.3±3.3 years. History of DKA was 
mostly negative (83.3%) in them. The mean breastfeeding duration was 
21±3.2 months, and only one had started formula after 12 months of birth. 
Conclusions: The results of the current study showed that the frequency 
of CD in T1DM children in north of Iran was similar to that other 
countries but lower than that in previous reports of Iran. The periodic 
screening test for CD in this high-risk group is necessary to diagnose the 
asymptomatic disease and prevent its complications. 
Keywords: Diabetes Mellitus Type 1, Celiac Disease, Pediatrics, 
Mazandaran 
 
 
 
 
 
 
Introduction: 
Diabetes mellitus, type 1 (T1DM) and celiac disease (CD) are both 
immune-mediated diseases. Human leukocyte antigen (HLA) as a genetic 
factor plays a significant role in their etiology. In addition, environmental 
factors interfere with their pathogenesis. The incidence of both diseases is 
growing worldwide. The rate of a clinical overlap of T1DM and CD was 
well studied in a review article and reported between 3.3% - 16.4% (with 
the mean of 8%), varying among countries 
[1]
. The prevalence of CD 
increased significantly after 1994 (from 3.3 to 10.6%); this rapid change 
could be related to environmental factors, eating habits and viral 
infections 
[2, 3]
. One third of HLA DQ2 homozygous patients with T1DM 
express celiac disease-associated transglutaminase autoantibodies. Auto-
immunity to transglutaminase is remarkably prevalent amongst patients 
with T1DM, expressing specific class II HLA alleles 
[4]
. 
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HLA-DQ 1*0501, 1*0201 heterodimer presents gluten-
derived gliadin peptides on its antigen-presenting 
groove to stimulate intestinal mucosal T-cells 
[2]
. 
CD defines as a systemic immune-mediated 
enteropathy, which flares when specific serum 
antibodies respond to the dietary gluten. Classic 
presentations are gastrointestinal signs and symptoms, 
including diarrhea, bloating, weight loss and growth 
failure due to the malabsorption. Most patients with 
underlying T1DM do not experience the typical signs 
and symptoms of CD, which makes the diagnosis 
difficult 
[1]
. Celiac disease is found more in patients 
with insulin-dependent diabetes mellitus or 
autoimmune thyroid disease 
[5]
. If CD is left untreated, 
the absorption of dietary antigens will increase through 
impaired intestinal permeability and induce the 
autoimmune reaction in individuals who are genetically 
susceptible to the autoimmune diseases 
[3]
. 
The gold standard diagnostic test for CD is the 
small intestinal biopsy, but there are also serologic tests 
like the anti-endomysial antibody (anti-EMA) and 
tissue transglutaminase immunoglobulin A (tTG-IgA) 
antibody which are highly specific and sensitive as 
well as useful for screening 
[6]
. Using HLA type DQ2 
and DQ8 as the initial screening test for CD is only 
recommended for Down syndrome because this is an 
expensive test 
[7]
. 
TTG-IgA antibodies testing should be performed 
with a diet consisting of at least 3g of gluten per day 
for at least six weeks; otherwise, serology may become 
negative within weeks of a gluten-free diet 
[7]
.  
Children with suggestive symptoms of CD or in 
high-risk groups regardless of having symptoms should 
undergo screening tests. Children with T1DM are one 
of these high-risk groups 
[7]
. Guidelines encourage 
testing celiac in individuals who have first-degree 
relatives with celiac disease, autoimmune thyroiditis, 
and T1DM 
[8]
. Complications of untreated CD in 
T1DM children could be the reduced Body Mass Index 
standard deviation score (BMI SDS) and lowered 
Hemoglobin A1c (HbA1c); a gluten-free diet helps to 
improve the BMI SDS and HbA1c without glycemic 
control, worsening during puberty 
[9]
. The approach to 
high-risk children for CD who are asymptomatic 
differs depending on the tTG-IgA antibodies results. If 
the test is strongly positive (>3 times the upper limit of 
normal), an endoscopic biopsy is recommended. If 
tTG-IgA antibodies are mildly elevated (positive but 
<3 times the upper limit of normal), subsequent testing 
with anti-EMA is suggested. If tTG-IgA antibodies are 
negative, patients should be under observation and if 
the symptoms develop, repeat the tests 
[7]
. 
The aim of this study was to determine the 
frequency of celiac disease in the pediatrics with 
T1DM in Mazandaran province, and evaluate the 
possible risk factors. 
 
 
Methods: 
The present study retrospectively reviewed all 
children who were diagnosed with T1DM from six 
months to 18 years old, referred to Baghban Clinic in 
Sari, Mazandaran from 2012 to 2014. This clinic is one 
of the pediatric endocrinology referral centers in 
Mazandaran province.  
Screening contained all individuals a) whose first 
presentation of diabetes was with diabetic ketoacidosis 
(DKA), b) had a history of DKA and positive anti 
GAD65 antibody, and c) needed insulin therapy. 
Children aged less than six months were excluded from 
the current study because the introduction of a gluten-
containing diet usually happens after six months of 
birth. To evaluate the presence of CD, all patients 
underwent tTG-IgA antibodies test at the time of 
diabetes diagnosis. All of the tTG-IgA antibodies tests 
were performed on a volume of 2-3 milliliter of whole 
blood using the enzyme-linked immunosorbent assay 
(ELISA) method with a standard kit (Euroimmun, 
Germany) in the same laboratory at Baghban Clinic. 
We selected the patients with positive tTG-IgA 
antibodies test (>50 Ru/ml) for endoscopic biopsy. 
Considering the high prevalence of IgA deficiency in 
CD, the total IgA was measured in all patients. 
Patients' demographics, history of birth (term or 
preterm, cesarean or vaginal delivery), fetal growth, 
DKA, and the age of diabetes diagnosis, breastfeeding 
duration, use of formula and cow's milk, history of 
using supplements (vitamin D), and a family history of 
diabetes and CD were extracted from files or verbally 
recorded in the questionnaire. 
Data analysis was performed using SPSS 16 and 
categorical data were tested using chi-square and 
quantitative data with T independent simple test. Data 
was reported with 95% confidence interval. P<0.05 
was statistically considered significant. 
The study was approved by the Ethics Committee 
of the Mazandaran University of Medical Sciences. All 
data were collected anonymously. All the principles 
outlined in the Helinski Declaration have been 
followed during the current study. 
  
267 | P a g e              Caspian Journal of Pediatrics, March 2018; Vol 4(No 1), Pp: 265-70 
Results: 
Of the 119 children enrolled in the study, the 
proportion of girls to boys was similar (50.4% girls, 
49.6% boys) and the mean age was 10.7±4.4 years. 
Table 1 illustrates the patients' demographics. 
In six cases (5%), who were all boys (P=0.013), 
tTG-IgA antibodies tests were positive. Their mean age 
was 10.3±3.3 years, and the mean age of diabetes 
diagnosis was 6±3.5 years. All were term babies. 
History of DKA was mostly negative (83.3%) in cases. 
All were breastfed for a mean duration of 21±3.2 
months. Only one case started formula after 12 months 
of birth. Five cases began feeding with cow's milk from 
the age of 6 months, and one after 18 months. All 6 
cases underwent endoscopic biopsy. The histopatholo-
gical results confirmed CD in 5 persons (4.2%). 
Only one of 119 cases had a positive family history 
of CD, whose anti-tTG test was negative. A family 
history of diabetes was positive in 50.4% of the 
patients. Between positive and negative tTG-IgA 
antibodies tests groups, except for gender, there was no 
statically significant difference in factors such as type 
of delivery, birth weight, family history of CD, formula 
feeding or the use of vitamins and supplements during 
infancy. Table 2 shows all the aspects considered for 
CD in our type 1 diabetes population. 
For one of the seropositive cases with no evidence 
of CD in his biopsy, an anti-tTG test was repeated after 
nine months and he underwent the endoscopic biopsy. 
There was no sign of pathologic changes, too. 
 
Table 1: Patients with type 1 diabetes 
characteristics 
Characteristics n (%) 
Sex 
Male 
Female 
59 (49.6) 
60 (50.4) 
Type of delivery 
Vaginal  
Cesarean  
81 (68) 
38 (32) 
Preterm 
Term 
7 (5.9) 
112 (94.1) 
Relative parents 21 (17.6) 
History of hospitalization 27 (22.6) 
Family history of diabetes 56 (47.0) 
GDM history in mother 6 (5.0) 
DKA history 23 (19.3) 
Fed by breast 118 (99.1) 
Vitamin D use in infancy 113 (95) 
Fed by formula 17 (14.2) 
Caw milk use 118 (99.1) 
Anti tTG positive 6 (5.0) 
GDM: gestational diabetes mellitus,  
DKA: diabetes ketoacidosis,  
tTG IgA: tissue transglutaminase immunoglobulin
 
Table 2: Comparing factors for CD in T1DM children 
Factors 
Anti tTG (mean±SD) / n (%) 
P value Positive 
(n=6) 
Negative 
(n=113) 
Birth weight (gr)  3150±367.4 3157.8± 678.3 0.978 
Age (years)  10.3±3.3 10.7±4.4 0.840 
Age at diabetes diagnosis (years) 6±3.5 6.8±3.4 >0.05 
Age at formula start (month)  6.0±0.0 5.98±0.3 >0.05 
Duration of breastfeeding (month)  21.0±3.2 22.0±4.0 >0.05 
Sex 
Male 6 (100) 
0 (0) 
53(46.9) 
50 (44.2) 
0.013 
Female 
Gestational age 
Preterm 0 (0) 
6 (100) 
7 (6.2) 
106 (93.8) 
>0.05 
>0.05 Term 
Cesarean delivery 2 (33.3) 36 (31.8) >0.05 
Relative parents 2 (33.3) 19 (16.8) 0.286 
Family history of diabetes  2 (33.3) 52 (46) 0.683 
GDM history in mothers 0 (0) 6 (5.3) 0.1 
DKA history 1 (16.6) 22 (19.4) >0.05 
Breastfed 6 (100) 112 (99.1) >0.05 
Vitamin D use in infancy  5 (83.3) 108 (95.5) >0.05 
Fed by formula 1 (16.6) 16 (14.1) >0.05 
Cow's milk use 6 (100) 113 (100) >0.05 
CD: celiac disease, T1D: type 1 diabetes mellitus, GDM: gestational diabetes 
mellitus, DKA: diabetes ketoacidosis, tTG IgA: tissue transglutaminase 
immunoglobulin 
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Discussion: 
Based on the results of this study, the frequency of 
CD in the T1DM children population was 5%. 
According to a review article published by Chon et 
al.’s this rate is higher in some countries like France 
and Estonia (3.4% and 3.3% respectively), but less than 
the mean prevalence of 8%, reported from different 
countries and a study in Iran 
[1]
. However, Zamanfar et 
al.’s reviewed three articles in which the prevalence of 
CD was from 4.3 to 6.8% in T1DM Iranian patients 
[10]
. 
They have found a mean prevalence of 5.6% which is 
similar to our finding. 
A systematic review investigated the overall 
prevalence of CD in different cities in Iran and various 
health conditions and it was concluded that 3% of 
patients had positive serologic tests and CD was 
confirmed in 2% of them via biopsy 
[8]
. The 
asymptomatic CD is typical in the Middle East as in 
Europe. It could be because the Iranian diet is mostly 
based on wheat, and high exposure to wheat proteins 
develops immune tolerance 
[11]
. Our seropositive cases 
were asymptomatic, too. 
More than ten years ago, Shahbazkhani and et al.’s 
reported a different prevalence of CD among 
subgroups, in which 2.4% of CD cases had T1DM 
[12]
. 
One of the possible reasons for that low rate of CD is 
the development of highly specific and sensitive 
screening tests in previous decades. 
The occurrence of CD is geographically variable. In 
our country, the prevalence of CD is reported 3% in 
central, 1% in northern, 2% in southern, 5% in western 
and 4% in eastern areas 
[13]
. CD rate is growing in 
developing regions such as the Middle-East where diets 
are high in grains, especially wheat 
[14]
. The first report 
of CD prevalence in Sari was 0.8% in the adult 
population in 2004. At that time this rate was similar to 
western countries 
[15]
.  
A newer study, Fallahi et al.’s found CD in 6.25% 
of children with T1DM using tTG antibody. 
Histopathological changes were compatible with CD in 
intestinal biopsies in all cases 
[16]
. Results of the present 
study were between those of Shahbazkhani and Fallahi 
studies, but the prevalence of CD in Iranian patients 
with T1DM seems relatively high which makes it more 
important to screen CD in these children regardless of 
the presence or absence of symptoms.  
Wheat content has been high in the Iranian diet for 
thousands of years, alongside the presence of about 
57.6% frequency of HLA DQ2 and DQ8 in the general 
population suggests that a high percentage of our 
community can be susceptible to different pre-
sentations of CD 
[17]
.  
Prolonged breastfeeding in developing countries as 
an environmental factor might be responsible for the 
milder symptoms and a higher age of CD diagnosis 
[18]
. 
The mean duration of breastfeeding in the CD positive 
cases was 21 months. A delayed gluten introduction or 
a gradual introduction of gluten-containing food to 
breastfeed the infants can be related to a later onset of 
the disease, which can protect against the development 
of CD during early childhood 
[19]
. 
Prevalence of CD is not different between male and 
female in the general Iranian population 
[17]
. The causes 
of gender differences in CD are supposed to be 
physiological and men have evidence of greater 
malabsorption than females 
[20]
. A cohort study 
represented that girls were significantly more 
predisposed to have T1DM and CD 
[21]
. All the CD 
positive patients in this study were boys; however, the 
proportion of both genders was equal in our T1DM 
patients. 
The results of a cohort study showed that there was 
a statistically significant increased risk of ketoacidosis 
in females with CD before the age of 20 
[22]
. Only one 
of six CD cases had a history of DKA.  
Cesarean section was not related to develop the CD 
in this study. The potential influence of alteration of 
microbial exposures and the bacterial colonization in 
neonates born with cesaeian delivery on pathogenesis 
intestinal inflamatoary diseases like CD have been 
discussed by Decker et al.’s but there is need for more 
investigation in this area 
[23]
.  
An American study on presentation of celiac in 
pediatrics found that prenatal factors including fetal 
growth, birth weight, mode of delivery, parental 
smoking, and maternal education did not associate with 
developing CD 
[24]
. Our findings were in accordance 
with these results. 
Vitamin D supplementation during infancy is 
proven to reduce the risk of T1DM 
[25]
. By 
consideration of common genetic basis for T1DM and 
CD, we would have found no reduction in the 
incidence of CD if patients had taken vitamin D 
supplements during infancy. 
In this retrospective study, the frequency of CD in 
type 1 diabetic children (5%) was similar to that of 
other countries but lower than that in previous reports 
of Iran. The only significant difference between CD 
positive and negative patients was gender. The periodic 
screening test for CD in type 1 diabetic patients is 
necessary to diagnose the asymptomatic, milder 
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symptomatic and silent CD and prevent its 
complications. 
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